InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: geocappy1 post# 324934

Tuesday, 02/20/2018 12:11:55 PM

Tuesday, February 20, 2018 12:11:55 PM

Post# of 346385

It appears they must have sold off Exsomes, biomarkers, etc in this "deal".



We can't be sure since Lias only said "bulk.."

Bulk = greater part ...but the least bulky part of IP may be worth the bulk of the assessment value vs the rest

Hence....we need the Roth opinion and see how many key expert witnesses they used for their due diligence and ROTH typically gets paid for each KOL they use to assess values and if they were not allowed to do so ....

We have failure of Fiduciary Duties .....which brings us full circle back to needing to view the full contract with Oncologie

The finger pointing has already begun
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News